• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Lauran Neergaard

Stay informed with Lauran Neergaard’s coverage and analysis for Fortune.

    Page 5 of 5

  • Doses of the Pfizer Covid-19 vaccine await to be administered after it was approved for use by the FDA in children 12 and over at a Los Angeles County mobile vaccination clinic on May 14, 2021 in Los Angeles, California. (Photo by Patrick T. FALLON / AFP) (Photo by PATRICK T. FALLON/AFP via Getty Images)Health

    Pfizer COVID-19 vaccine gets full approval from U.S. FDA

    By Lauran Neergaard, Matthew Perrone, and others
  • Vials of Pfizer Covid-19 vaccine and sodium cloride (used for dilution of the vaccine) are seen  at a community vaccination event in a predominately Latino  neighborhood in Los Angeles, California, August 11, 2021. – All teachers in California will have to be vaccinated against Covid-19 or submit to weekly virus tests, Governor Gavin Newsom  announced on August 11, as authorities grapple with exploding infection rates. The number of people testing positive for the disease has surged in recent weeks, with the highly infectious Delta variant blamed for the bulk of new cases. (Photo by Robyn Beck / AFP) (Photo by ROBYN BECK/AFP via Getty Images)Health

    The FDA says Americans with weakened immune systems can now get a Pfizer or Moderna booster shot

    By Lauran Neergaard, Matthew Perrone, and others
  • 07 May 2021, Saxony-Anhalt, Halberstadt: Klaus Begall, professor at the Ameos Clinic in Halberstadt, shows an empty vial that once contained doses of Biontech-Pfizer’s vaccine. The vial is one of those that were already vaccinated in Germany on December 26, 2021, at the Ameos Clinic, as vaccination against the coronavirus began in Halberstadt one day earlier than planned nationwide. In the morning, several of these vials had been handed over to the municipal museum. The municipal collections hold contemporary historical documents and objects of high importance. Photo: Klaus-Dietmar Gabbert/dpa-Zentralbild/dpa (Photo by Klaus-Dietmar Gabbert/picture alliance via Getty Images)Health

    Pfizer COVID-19 vaccine gets go-ahead for children as young as 12

    By Lauran Neergaard, Candice Choi, and others
  • Medical syringes are seen with Johnson & Johnson logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on April 14, 2021.Health

    U.S. officials say they need more time to weigh J&J vaccine risks

    By Lauran Neergaard, Mike Stobbe, and others
  • MARBURG, GERMANY – MARCH 29: Employees in special suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine in German company BioNTech, in Marburg, Germany on March 29, 2021. BioNTech Marburg’s coronavirus vaccine production target will be 2.5 billion doses for 2021, up from 2.3 billion as it is considered as one of the largest manufacturing facilities producing mRNA vaccines in the world. The Pfizer-BioNTech vaccine was developed by Ozlem Tureci and Ugur Sahin, a couple who are children of Turkish immigrants in Germany. (Photo by Abdulhamid Hosbas/Anadolu Agency via Getty Images)Health

    Pfizer says its COVID vaccine is safe for children as young as 12

    By Lauran Neergaard and The Associated Press
  • Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks about the coronavirus in the Rose Garden of the White House.Health

    White House turns to statistical models for coronavirus forecast

    By Ricardo Alonso-Zaldivar, Lauran Neergaard, and others
  • US-HEALTH-VIRUS-CHINAPolitics

    Trump puts Pence in charge of coronavirus efforts, calls risk to Americans ‘very low’

    By Lauran Neergaard, Ricardo Alonso-Zaldivar, and others
  • GHANA-HEALTH-VACCINES-MALARIAHealth

    Groundbreaking malaria vaccine test underway in 3 African nations

    By Cara Anna, Lauran Neergaard, and others
  • Senator Bernie Sanders Joins The Chicago Teachers Union StrikePolitics

    Bernie Sanders Hospitalized for Blockage in Artery, Cancels Campaign Events

    By Nicholas Riccardi, Lauran Neergaard, and others
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.